David DiLillo
6Patents
1h-index
10Co-inventors
40Inventor score
Filing activity: Jul 18, 2019 → Oct 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11384153B2 | Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US11826386B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11905332B2 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12258412B2 | Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12150959B2 | Chimeric antigen receptors with BCMA specificity and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12291559B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.